-
Signature
-
/s/ Gordon Esplin as attorney-in-fact for Troy E. Wilson
-
Stock symbol
-
PBYI
-
Transactions as of
-
Jun 13, 2025
-
Transactions value $
-
-$36,720
-
Form type
-
4
-
Date filed
-
6/17/2025, 07:55 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| WILSON TROY EDWARD |
Director |
C/O PUMA BIOTECHNOLOGY, INC., 10880 WILSHIRE BOULEVARD, SUITE 2150, LOS ANGELES |
/s/ Gordon Esplin as attorney-in-fact for Troy E. Wilson |
2025-06-17 |
0001589597 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PBYI |
Common Stock |
Sale |
-$36.7K |
-10.8K |
-19.87% |
$3.40 |
43.6K |
Jun 13, 2025 |
Direct |
F1, F2 |
| holding |
PBYI |
Common Stock |
|
|
|
|
|
400 |
Jun 13, 2025 |
By Child #1 |
|
| holding |
PBYI |
Common Stock |
|
|
|
|
|
150 |
Jun 13, 2025 |
By Child #2 |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: